相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Germline Pathogenic Variants in 7636 Japanese Patients With Prostate Cancer and 12 366 Controls
Yukihide Momozawa et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation
Max M. Wattenberg et al.
BRITISH JOURNAL OF CANCER (2020)
PARP and PARG inhibitors in cancer treatment
Dea Slade
GENES & DEVELOPMENT (2020)
Targeting cervical cancer: Is there a role for poly (ADP-ribose) polymerase inhibition?
Federica Tomao et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Randomized, Multicenter, Phase II Trial of Gemcitabine and Cisplatin With or Without Veliparib in Patients With Pancreas Adenocarcinoma and a Germline BRCA/PALB2 Mutation
Eileen M. O'Reilly et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families
Xin Yang et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing Cohort
Chunling Hu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
NCCN: Continuing Education
Mary B. Daly et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Dramatic response to PARP inhibition in a PALB2-mutated breast cancer: moving beyond BRCA
T. Grelletyy et al.
ANNALS OF ONCOLOGY (2020)
Olaparib for metastatic breast cancer in a patient with a germline PALB2 variant
Sherko Kuemmel et al.
NPJ BREAST CANCER (2020)
Pan-Cancer Analysis of BRCA1 and BRCA2 Genomic Alterations and Their Association With Genomic Instability as Measured by Genome-Wide Loss of Heterozygosity
Ethan S. Sokol et al.
JCO PRECISION ONCOLOGY (2020)
PARP Inhibitors: Extending Benefit Beyond BRCA-Mutant Cancers
Patrick G. Pilie et al.
CLINICAL CANCER RESEARCH (2019)
Germline heterozygous BLM mutations and prostate cancer risk.
Elisa Ledet et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Functional analysis of BARD1 missense variants in homology-directed repair and damage sensitivity
Aleksandra I. Adamovich et al.
PLOS GENETICS (2019)
Associations between XRCC3 Thr241Met polymorphisms and breast cancer risk: systematic-review and meta-analysis of 55 case-control studies
Sepideh Dashti et al.
BMC MEDICAL GENETICS (2019)
Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer
Na Li et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Tumour lineage shapes BRCA-mediated phenotypes
Philip Jonsson et al.
NATURE (2019)
Inherited variants in XRCC2 and the risk of breast cancer
Wojciech Kluzniak et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
MRE11-RAD50-NBS1 complex alterations and DNA damage response: implications for cancer treatment
Lei Bian et al.
MOLECULAR CANCER (2019)
ATM Dysfunction in Pancreatic Adenocarcinoma and Associated Therapeutic Implications
Samantha A. Armstrong et al.
MOLECULAR CANCER THERAPEUTICS (2019)
Association of Breast and Ovarian Cancers With Predisposition Genes Identified by Large-Scale Sequencing
Hsiao-Mei Lu et al.
JAMA ONCOLOGY (2019)
ATM Regulated PTEN Degradation Is XIAP E3 Ubiquitin Ligase Mediated in p85α Deficient Cancer Cells and Influence Platinum Sensitivity
Reem Ali et al.
CELLS (2019)
53BP1: A key player of DNA damage response with critical functions in cancer
Mohammad Mirza-Aghazadeh-Attari et al.
DNA REPAIR (2019)
The Tumor Suppressor PALB2: Inside Out
Mandy Ducy et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer
Nana Weber-Lassalle et al.
BREAST CANCER RESEARCH (2019)
Homologous recombination DNA repair defects in PALB2-associated breast cancers
Anqi Li et al.
NPJ BREAST CANCER (2019)
Inherited DNA-Repair Defects in Colorectal Cancer
Saud H. AlDubayan et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Genetic variants in ATM, H2AFX and MRE11 genes and susceptibility to breast cancer in the polish population
Marta Podralska et al.
BMC CANCER (2018)
Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes
Lepakshi Ranjha et al.
CHROMOSOMA (2018)
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance
Marcia Irene Canto et al.
GASTROENTEROLOGY (2018)
Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer
Chunling Hu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
Hermela Shimelis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2018)
RAD-ical New Insights into RAD51 Regulation
Meghan R. Sullivan et al.
GENES (2018)
The contribution of XRCC3 genotypes to childhood acute lymphoblastic leukemia
Jen-Sheng Pei et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Contribution of germline deleterious variants in the RAD51 paralogs to breast and ovarian cancers
Lisa Golmard et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2017)
Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls
Jenna Lilyquist et al.
GYNECOLOGIC ONCOLOGY (2017)
Rare, protein-truncating variants in ATM, CHEK2 and PALB2, but not XRCC2, are associated with increased breast cancer risks
Brennan Decker et al.
JOURNAL OF MEDICAL GENETICS (2017)
High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway
Nicholas A. Wallace et al.
JOURNAL OF VIROLOGY (2017)
Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial
Yung-Jue Bang et al.
LANCET ONCOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Olga Kondrashova et al.
CANCER DISCOVERY (2017)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
Defects in recombination activity caused by somatic and germline mutations in the multimerization/BRCA2 binding region of human RAD51 protein
Michelle C. Silva et al.
DNA REPAIR (2017)
Human Papillomavirus in Cervical Cancer and Oropharyngeal Cancer: One Cause, Two Diseases
Tara A. Berman et al.
CANCER (2017)
The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
Thomas P. Slavin et al.
NPJ BREAST CANCER (2017)
High Expression of MRE11-RAD50-NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
Bolag Altan et al.
ANTICANCER RESEARCH (2016)
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
Melinda L. Telli et al.
CLINICAL CANCER RESEARCH (2016)
RAD51 variant proteins from human lung and kidney tumors exhibit DNA strand exchange defects
Michelle C. Silva et al.
DNA REPAIR (2016)
Penetrance of ATM Gene Mutations in Breast Cancer: A Meta-Analysis of Different Measures of Risk
Monica Marabelli et al.
GENETIC EPIDEMIOLOGY (2016)
Copy number deletion of RAD50 as predictive marker of BRCAness and PARP inhibitor response in BRCA wild type ovarian cancer
Min Zhang et al.
GYNECOLOGIC ONCOLOGY (2016)
TOPBP1 regulates RAD51 phosphorylation and chromatin loading and determines PARP inhibitor sensitivity
Pavel Moudry et al.
JOURNAL OF CELL BIOLOGY (2016)
Panel Testing for Familial Breast Cancer: Calibrating the Tension Between Research and Clinical Care
Ella R. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing
Douglas F. Easton et al.
JOURNAL OF MEDICAL GENETICS (2016)
PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS
Melissa C. Southey et al.
JOURNAL OF MEDICAL GENETICS (2016)
Gastric Cancer, Version 3.2016
Jaffer A. Ajani et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
TopBPI contributes to the chemoresistance in non-small cell lung cancer through upregulation of p53
Yinxiang Lv et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2016)
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist et al.
JAMA ONCOLOGY (2016)
RAD51B in Familial Breast Cancer
Liisa M. Pelttari et al.
PLOS ONE (2016)
Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon Cancer
Ozkan Ozden et al.
SCIENTIFIC REPORTS (2016)
Targeting homologous recombination, new pre-clinical and clinical therapeutic combinations inhibiting RAD51
Ambber Ward et al.
CANCER TREATMENT REVIEWS (2015)
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
Yung-Jue Bang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population
Honglin Song et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Inherited Mutations in 17 Breast Cancer Susceptibility Genes Among a Large Triple-Negative Breast Cancer Cohort Unselected for Family History of Breast Cancer
Fergus J. Couch et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
A Dominant Mutation in Human RAD51 Reveals Its Function in DNA Interstrand Crosslink Repair Independent of Homologous Recombination
Anderson T. Wang et al.
MOLECULAR CELL (2015)
A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51
Najim Ameziane et al.
NATURE COMMUNICATIONS (2015)
Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer
Richarda M. de Voer et al.
SCIENTIFIC REPORTS (2015)
Helicobacter pylori Infection Causes Characteristic DNA Damage Patterns in Human Cells
Max Koeppel et al.
CELL REPORTS (2015)
Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment
Andrea Desmond et al.
JAMA ONCOLOGY (2015)
Prevalence of the BLM nonsense mutation, p.Q548X, in ovarian cancer patients from Central and Eastern Europe
Natalia Bogdanova et al.
FAMILIAL CANCER (2015)
Tumor-associated mutations in a conserved structural motif alter physical and biochemical properties of human RAD51 recombinase
Jianhong Chen et al.
NUCLEIC ACIDS RESEARCH (2015)
A Synthetic Lethal Screen Identifies DNA Repair Pathways that Sensitize Cancer Cells to Combined ATR Inhibition and Cisplatin Treatments
Kareem N. Mohni et al.
PLOS ONE (2015)
Poly (ADP-ribose) polymerase inhibitor LT-626: Sensitivity correlates with MRE11 mutations and synergizes with platinums and irinotecan in colorectal cancer cells
Lisa A. McPherson et al.
CANCER LETTERS (2014)
TopBP1: A BRCT-scaffold protein functioning in multiple cellular pathways
Christopher P. Wardlaw et al.
DNA REPAIR (2014)
53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
James M. Daley et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro
Romana Koppensteiner et al.
PLOS ONE (2014)
Synthetic Lethality in ATM-Deficient RAD50-Mutant Tumors Underlies Outlier Response to Cancer Therapy
Hikmat Al-Ahmadie et al.
CANCER DISCOVERY (2014)
Rare key functional domain missense substitutions in MRE11A, RAD50, and NBN contribute to breast cancer susceptibility: results from a Breast Cancer Family Registry case-control mutation-screening study
Francesca Damiola et al.
BREAST CANCER RESEARCH (2014)
An inherited NBN mutation is associated with poor prognosis prostate cancer
C. Cybulski et al.
BRITISH JOURNAL OF CANCER (2013)
A common nonsense mutation of the BLM gene and prostate cancer risk and survival
Andrzej Antczak et al.
GENE (2013)
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease
David N. Cooper et al.
HUMAN GENETICS (2013)
The Mre11 Complex Suppresses Oncogene-Driven Breast Tumorigenesis and Metastasis
Gaorav P. Gupta et al.
MOLECULAR CELL (2013)
Evaluation of candidate biomarkers to predict cancer cell sensitivity or resistance to PARP-1 inhibitor treatment
Lenka Oplustilova et al.
CELL CYCLE (2012)
High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia
Anna P. Sokolenko et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Role of MRE11 in Cell Proliferation, Tumor Invasion, and DNA Repair in Breast Cancer
Shyng-Shiou F. Yuan et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Expression of TopBP1 in hereditary breast cancer
Ewa Forma et al.
MOLECULAR BIOLOGY REPORTS (2012)
RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
Florence Le Calvez-Kelm et al.
PLOS ONE (2012)
First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes
Monika Morak et al.
EUROPEAN JOURNAL OF CANCER (2011)
High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome
Raffaela Barbano et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Germline mutations in RAD51D confer susceptibility to ovarian cancer
Chey Loveday et al.
NATURE GENETICS (2011)
Mutations in BRIP1 confer high risk of ovarian cancer
Thorunn Rafnar et al.
NATURE GENETICS (2011)
Molecular disruption of NBS1 with targeted gene delivery enhances chemosensitisation in head and neck cancer
K. Araki et al.
BRITISH JOURNAL OF CANCER (2010)
Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
Norman Chan et al.
CANCER RESEARCH (2010)
Radiation Exposure, the ATM Gene, and Contralateral Breast Cancer in the Women's Environmental Cancer and Radiation Epidemiology Study
Jonine L. Bernstein et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers
Peter Bouwman et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination
Remi Buisson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Human RAD50 Deficiency in a Nijmegen Breakage Syndrome-like Disorder
Regina Waltes et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2009)
Two Brothers with Ataxia-Telangiectasia-like Disorder with Lung Adenocarcinoma
Naoki Uchisaka et al.
JOURNAL OF PEDIATRICS (2009)
Regulation of p53 by TopBP1: a Potential Mechanism for p53 Inactivation in Cancer
Kang Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Chronic hypoxia decreases synthesis of homologous recombination proteins to offset chemoresistance and radioresistance
Norman Chan et al.
CANCER RESEARCH (2008)
NBS1 Heterozygosity and Cancer Risk
Alessandra Masi et al.
CURRENT GENOMICS (2008)
Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene
Jirina Bartkova et al.
MOLECULAR ONCOLOGY (2008)
Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex
Huan-Ming Hsu et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Altered DNA binding by the human Rad51-R150Q mutant found in breast cancer patients
Takako Ishida et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2007)
Germline alterations in the 53BP1 gene in breast and ovarian cancer families
Katrin Rapakko et al.
CANCER LETTERS (2007)
Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer
Sanna-Maria Karppinen et al.
EUROPEAN JOURNAL OF CANCER (2006)
Germline mutations 657del5 of the NBS1 gene contribute significantly to the incidence of breast cancer in Central Poland
J Steffen et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Evaluation of RAD50 in familial breast cancer predisposition
J Tommiska et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Carrier frequency of mutation 657del5 in the NBS1 gene in a population of Polish pediatric patients with sporadic lymphoid malignancies
KH Chrzanowska et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models
S Difilippantonio et al.
NATURE CELL BIOLOGY (2005)
The RAD51 gene family, genetic instability and cancer
J Thacker
CANCER LETTERS (2005)
ATM sequence variants are predictive of adverse radiotherapy response among patients treated for prostate cancer
JA Cesaretti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
NBS1 is a prostate cancer susceptibility gene
C Cybulski et al.
CANCER RESEARCH (2004)
Functional consequences of sequence alterations in the ATM gene
MF Lavin et al.
DNA REPAIR (2004)
Exploiting tumour hypoxia in cancer treatment
JM Brown et al.
NATURE REVIEWS CANCER (2004)
Mutation screening of Mre11 complex genes:: indication of RAD50 involvement in breast and ovarian cancer susceptibility -: art. no. e131
K Heikkinen et al.
JOURNAL OF MEDICAL GENETICS (2003)
BLM heterozygosity and the risk of colorectal cancer
SB Gruber et al.
SCIENCE (2002)
BARD1 induces BRCA1 intranuclear foci formation by increasing RING-dependent BRCA1 nuclear import and inhibiting BRCA1 nuclear export
M Fabbro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs
M Takata et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Identification of Rad51 alteration in patients with bilateral breast cancer
M Kato et al.
JOURNAL OF HUMAN GENETICS (2000)
分享论文
